Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells
- 1 August 2012
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 53 (4) , 758-768
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- Molecular cross-regulation between PPAR-γ and other signaling pathways: Implications for lung cancer therapyLung Cancer, 2011
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers RadioresistanceAntioxidants & Redox Signaling, 2010
- Deficiency in the Nuclear Factor E2-related Factor-2 Transcription Factor Results in Impaired Adipogenesis and Protects against Diet-induced ObesityJournal of Biological Chemistry, 2010
- Dose-dependent transitions in Nrf2-mediated adaptive response and related stress responses to hypochlorous acid in mouse macrophagesToxicology and Applied Pharmacology, 2009
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences, 2008
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2Carcinogenesis, 2008
- Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alphaProceedings of the National Academy of Sciences, 2007
- Molecular mechanism of human Nrf2 activation and degradation: Role of sequential phosphorylation by protein kinase CK2Free Radical Biology and Medicine, 2007